Literature DB >> 36227508

Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis.

Sin Young Ham1,2, Hyungul Jung1, Kyoung-Ho Song1,3, Hyeonju Jeong1, Jongtak Jung1, Song Mi Moon1,3, Jeong Su Park4, Nak-Hyun Kim1, Eun Sun Jang1,3, Jin-Wook Kim1,3, Sook-Hyang Jeong1,3, Eu Suk Kim5,6, Hong Bin Kim1,3.   

Abstract

This retrospective study aimed to clarify the interspecies differences in the clinical characteristics and risk factors of bloodstream infection (BSI) due to third-generation cephalosporin-resistant (3GC-R) Escherichia coli (EC) and Klebsiella pneumoniae (KP) in patients with liver cirrhosis (LC). KP BSI had more comorbidities and higher treatment failure rate than EC BSI. Non-alcoholic LC was a risk factor for treatment failure in EC, whereas it was not associated with KP. Risk factors for BSI due to 3GC-R strain were nosocomial infection in EC, and β-lactam/fluoroquinolone treatment ≤ 30 days in KP. These results could help predict outcomes of BSI and improve clinical practice.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bloodstream infection; Enterobacteriaceae; Interspecies difference; Liver cirrhosis; Mortality; Third-generation cephalosporin resistance

Year:  2022        PMID： 36227508     DOI： 10.1007/s10096-022-04508-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   5.103


  19 in total

1.  Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis.

Authors:  A M Thulstrup; H T Sørensen; H C Schønheyder; J K Møller; U Tage-Jensen
Journal:  Clin Infect Dis       Date:  2000-11-29       Impact factor: 9.079

Review 2.  Infectious complications of acute and chronic liver disease.

Authors:  Bettina Leber; Walter Spindelboeck; Vanessa Stadlbauer
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

3.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

Review 4.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

5.  Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Authors:  Hazuki Nakai; Mao Hagihara; Hideo Kato; Jun Hirai; Naoya Nishiyama; Yusuke Koizumi; Daisuke Sakanashi; Hiroyuki Suematsu; Yuka Yamagishi; Hiroshige Mikamo
Journal:  J Infect Chemother       Date:  2016-03-08       Impact factor: 2.211

6.  Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.

Authors:  R Leistner; S Gürntke; C Sakellariou; L A Denkel; A Bloch; P Gastmeier; F Schwab
Journal:  Infection       Date:  2014-08-07       Impact factor: 3.553

7.  Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study.

Authors:  Joshua T Freeman; Joseph Rubin; Gary N McAuliffe; Gisele Peirano; Sally A Roberts; Dragana Drinković; Johann Dd Pitout
Journal:  Antimicrob Resist Infect Control       Date:  2014-09-01       Impact factor: 4.887

8.  Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam.

Authors:  E A Reuland; N Al Naiemi; A M Kaiser; M Heck; J A J W Kluytmans; P H M Savelkoul; P J M Elders; C M J E Vandenbroucke-Grauls
Journal:  J Antimicrob Chemother       Date:  2016-01-10       Impact factor: 5.790

9.  Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

Authors:  Rajiv Jalan; Javier Fernandez; Reiner Wiest; Bernd Schnabl; Richard Moreau; Paolo Angeli; Vanessa Stadlbauer; Thierry Gustot; Mauro Bernardi; Rafael Canton; Agustin Albillos; Frank Lammert; Alexander Wilmer; Rajeshwar Mookerjee; Jordi Vila; Rita Garcia-Martinez; Julia Wendon; José Such; Juan Cordoba; Arun Sanyal; Guadalupe Garcia-Tsao; Vicente Arroyo; Andrew Burroughs; Pere Ginès
Journal:  J Hepatol       Date:  2014-02-12       Impact factor: 25.083

10.  Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.

Authors:  Christian Sakellariou; Stephan Gürntke; Ivo Steinmetz; Christian Kohler; Yvonne Pfeifer; Petra Gastmeier; Frank Schwab; Axel Kola; Maria Deja; Rasmus Leistner
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.